John Kevin Aurinia Pharmaceuticals (NASDAQ:AUPH) traded ~5% higher pre-market Thursday after the Canadian biotech increased its full-year guidance and posted…
Read More »Aurinia
lucadp Stock index futures rose early Friday following strong U.S. economic data, which grew much more than initially thought in…
Read More »